
Tribun Health is a company at the forefront of AI-powered digital pathology, transforming disease diagnosis for over 15 years by enabling the transition from microscopes to computers. Their platform offers a comprehensive suite of solutions for cancer diagnosis, including AI-driven tools for diagnosis, prognosis, and drug development. Key products include CaloPix®, an image management system; MacroCam for macroscopic image capture; CaloPix® Archive for secure data management; AI Apps for advanced image analysis; and TeleSlide® Patho for remote case sharing. Tribun Health serves both diagnostic laboratories and pharmaceutical/biotech companies, aiming to modernize pathology diagnostics globally. They have been recognized as a 3x winner of the Best in KLAS Digital Pathology award for their CaloPix® solution.

Tribun Health is a company at the forefront of AI-powered digital pathology, transforming disease diagnosis for over 15 years by enabling the transition from microscopes to computers. Their platform offers a comprehensive suite of solutions for cancer diagnosis, including AI-driven tools for diagnosis, prognosis, and drug development. Key products include CaloPix®, an image management system; MacroCam for macroscopic image capture; CaloPix® Archive for secure data management; AI Apps for advanced image analysis; and TeleSlide® Patho for remote case sharing. Tribun Health serves both diagnostic laboratories and pharmaceutical/biotech companies, aiming to modernize pathology diagnostics globally. They have been recognized as a 3x winner of the Best in KLAS Digital Pathology award for their CaloPix® solution.
What they do: AI-powered end-to-end digital pathology platform (CaloPix® IMS, MacroCam, AI Apps, Archive, TeleSlide®)
Headquarters: Paris, France
Founded: 2006
Customers / markets: Hospitals, diagnostic labs, pharma & biotech; international presence (Europe, North America)
Recent funding: Multiple rounds including Series B (€15M, 2023) and a grant round on 2024-04-23
| Company |
|---|
Digital pathology and computational pathology for diagnostic laboratories, hospitals, and pharmaceutical/biotech research.
2006
Medical Equipment Manufacturing
€15,000,000
Investors included Owkin, Vivalto Family/Partners, and renewed support from LBO France
“Bpifrance, LBO France, Owkin, Vivalto Partners”